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INTRODUCTION
Recent studies suggest that sphingolipids, in addition to
their function as structural cell membrane constituents, play
a key role as signaling molecules. In this regard, sphingolipid
metabolites, including ceramide, sphingosine, and sphingo-
sine 1-phosphate (S1P), have been identified as a new class
of lipid messengers, which regulate cell proliferation, differ-
entiation, and survival (1-3). S1P generated by sphingosine
kinase, an intracellular enzyme and has been associated with
the regulation of cell proliferation, differentiation, survival,
and motility (1-5). In contrast to the general association of
ceramide and sphingosine with cell growth arrest and apop-
tosis, S1P that is a downstream metabolite of ceramide, gen-
erally known to exert mitogenic and antiapoptotic effects (1-
4). One of the better-known sources of S1P are human pla-
telets, from which S1P is released upon activation by physio-
logical stimuli, thereby suggesting that S1P is a factor signi-
ficantly involved in endothelial injury, inflammation, throm-
bosis, angiogenesis, and wound healing via an induced increase
in the migration and proliferation of endothelial cells (6, 7).
S1P reaches levels of up to 0.2  M in normal plasma, and
may be as high as 10  M in normal serum, presumably reflect-
ing major contributions from platelets (8). 
More recently, S1P has been identified as a first messenger,
owing to its ability to bind and activate a series of G-protein
coupled receptors (GPCRs) located on the cell surface (9),
which have been designated S1P1 (endothelial differentiation
gene, Edg 1), S1P2 (Edg 5), S1P3 (Edg 3), S1P4 (Edg 6), S1P5
(Edg 8), by a nomenclature subcommittee of the International
Union of Pharmacologists (10, 11). S1P can function in either
an autocrine or paracrine fashion via Edg receptors (9). The
coupling of Edg receptors to diverse G proteins results in the
activation of a number of downstream signaling pathways.
Intracellular signaling pathways activated by Edg receptors
include adenyl cyclase, phospholipase C (PLC), Ras, mitogen-
activated protein kinase (MAPK), Rho, and several protein
tyrosine kinases (12-18). S1P also acts as an intracellular sec-
ond messenger to regulate calcium homeostasis, survival and
growth (12). Indeed, a variety of effects were observed in con-
junction with S1P, apparently depending on the cell type.
Recently, S1P has occasionally been associated with certain
growth-inhibitory and apoptotic effects in human hepatoma
cells, ovarian cancer cells, cultured hippocampal neurons,
and others (19-24).
In the present study, we have identified S1P receptors (Edg-
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Sphingosine 1-Phosphate Triggers Apoptotic Signal for B16 Melanoma
Cells via ERK and Caspase Activation
The bioactive sphingolipid metabolite sphingosine 1-phosphate (S1P), recently was
reported to induce apoptosis of some cancer cells and neurons, although it gener-
ally known to exert mitogenic and antiapoptotic effects. In this study, we investigat-
ed the effects of S1P on the cell growth, melanogenesis, and apoptosis of cultured
B16 mouse melanoma cells. In results, S1P was found to induce apoptosis in B16
melanoma cells in a dose- and time-dependent manner, but exerted minimal effects
on melanogenesis. Although receptors of sphingosine 1-phosphate (endothelial dif-
ferentiation gene 1 [Edg]/S1P1, Edg5/S1P2, Edg3/S1P3) were expressed in B16
melanoma cells, they were shown not to be associated with S1P-induced apopto-
sis. In addition, pertussis toxin did not block the apoptotic effects of S1P on B16
melanoma cells. S1P induced caspase-3 activation and the extracellular signal-reg-
ulated kinase (ERK) activation. Interestingly, the ERK pathway inhibitor, UO126,
reversed the apoptotic effects of S1P on B16 melanoma cells. These results sug-
gest that S1P induced apoptosis of B16 melanoma cells via an Edg receptor-inde-
pendent, pertussis toxin-insensitive pathway, and appears to be associated with
the ERK and caspase-3 activation. 
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1, -3, and -5) in B16 mouse melanoma cells, and investigat-
ed the actions of S1P on cell growth. S1P evidenced an anti-
proliferative effect on B16 mouse melanoma cells. S1P induced
apoptosis via caspase-3 activation, in an Edg receptor-inde-
pendent fashion. S1P activated the extracellular signal-reg-
ulated protein kinase (ERK) and UO126, the ERK pathway
inhibitor, reversed the apoptotic effects of S1P.
MATERIALS AND METHODS
Materials
Sphingosine 1-phosphate and dihydrosphingosine 1-phos-
phate were obtained from Calbiochem (SanDiego, CA, U.S.A.).
Stock sphingolipid solutions were dissolved in methanol
(S1P and dihydro-S1P). All stock solutions were maintained
at -80℃ until use. Dilutions of S1P and dihydro-S1P were
freshly prepared after the evaporation of methanol via resus-
pension in 0.4% fatty acid-free bovine serum albumin (BSA)
and sonication. UO126 and pertussis toxin were purchased
from the Sigma Co (Yongin, Korea). Stock UO126 solutions
were dissolved in Me2SO and maintained at -80℃ until use.
Culture media and reagents were obtained from Gibco (LA,
CA, U.S.A.), and fetal bovine serum (FBS) was obtained from
Omega (Tarzana, CA, U.S.A.). Mouse monoclonal antibody
against Edg-3, Edg-5 and rabbit polyclonal antibody against
Edg-1 were from Merk Korea (Seoul, Korea). Rabbit mono-
clonal anti-cleaved caspase-3 (Asp175) antibody was pur-
chased from Cell Signaling Technology, Inc (Danvers, MA,
U.S.A.). The ApopTag Kit (S7101) was purchased from the
Intergen Company (Norcross, Eeorgia, U.S.A.).
Cell culture 
B16 mouse melanoma cells (2×104) were seeded into 30-
mm culture dishes in maintenance medium (RPMI 1640
supplemented with 10% FBS, 1% streptomycin and peni-
cillin), and permitted to attach overnight. The medium was
then exchanged with serum-starved medium (0.25% FBS) for
48 hr, and treated with S1P or vehicle (PBS/BSA) for the indi-
cated time courses. Every 2 days, the medium was changed.
MTT dye-reduction assay
Cells (1×104 cells/well), seeded into 12-well plates for
24 hr in maintenance media and 48 hr for serum-starvation
media, and were incubated with the test substances for 24
hr at 37℃ in 5%CO2. After the addition of 100  L/well of
MTT solution (5 mg/mL), the plates were incubated for an
additional 4 hr. The supernatants were then removed, and
the formazan crystals were solubilized in 1 mL of dimethyl-
sulfoxide. Optical density was determined at a wavelength
of 540 nm, using an ELISA reader.
Melanin assay
For the quantitative analysis of melanin content, cells were
harvested and counted (2×105), and then centrifuged for 4
min with 100,000 r.p.m. After vortex, cells were incubated
in 1N of NaOH to lysis overnight at 37℃ and then optical
density was determined at 470 nm using an ELISA reader.
Immunocytochemistry for Edg receptors
Cells were grown for 24 hr on Lab-Tek chamber slides
(Nunc Inc., Naperville, IL, U.S.A.). The cells were then fixed
in 4% paraformaldehyde containing 0.1% Triton X-100
overnight at 4℃. Nonspecific binding sites were blocked
with blocking solution (20% normal goat serum, 0.1% BSA,
and 0.1% Triton X-100 in phosphate buffered solution [PBS])
for 10 min at room temperature. The cells were then incu-
bated for 25 min at 45℃ with mouse monoclonal antibody
against Edg-3, Edg-5 diluted to 1:50, and rabbit polyclonal
antibody against Edg-1 diluted to 1:100, in PBS. After wash-
ing with PBS, the cells were incubated with biotin-labeled
mouse anti-IgG antibody (1:200, DAKO, Carpinteria, CA,
U.S.A.) and streptavidin alkaline phosphate anti-alkaline
phosphate, for 15 min each at room temperature. The sub-
strate chromogen New fuchsin (ScyTek, Logan, UT, U.S.A.)
was also applied for 20 min. The cells were examined with a
Zeiss microscope. PBS instead of a primary antibody was
administered as a negative control.
In situ analysis of DNA integrity (TUNEL assay)
Cells were grown on Lab-Tek chamber slides (Nunc Inc.)
for 24 hr in maintenance medium to attach, after which the
medium was changed to fresh maintenance medium or serum-
starved medium (0.5% FBS) for 48 hr, then treated for 24 hr
with S1P or a vehicle. The nick-end-labeling (terminal deoxy-
nucleotidyl transferase-mediated dUTP TUNEL) technique
was conducted as described. In brief, the slides were fixed
for 10 min in 1% paraformaldehyde in PBS, and then washed
twice in PBS. The cells were preincubated for 2 min at room
temperature in equilibration buffer, and incubated for 1 hr
in a moisture chamber at 37℃ with a working strength (55
L/5 cm2) formulation of TdT enzyme (77  L of reaction
buffer with 33  L of TdT enzyme). The reaction was halted
via the transference of the slides to stop buffer (1 mL buffer
with 34 mL D/W) in a coplin jar, with 15 sec of agitation,
incubated for 10 min at room temperature, and then washed
three times in PBS. The cells were incubated for 30 min in
a moisture chamber at room temperature in anti-dioxigenin
peroxidase conjugate, and then washed four times in PBS.
DAB peroxidase substrate was applied to the stains for 10
min at room temperature, followed by washing in distilled
water. The cells were counterstained with 0.5% methyl green
in a coplin jar for 10 min at room temperature, then mount-300 J.-H. Shin, G.-S. Choi, W.-H. Kang, et al.
ed in an aqueous mounting medium (Niomeda, Foster City,
CA, U.S.A.). 
We utilized computerized image analysis to quantify the
number of apoptotic cells in each sample. A CCD camera
(CCD-IRIS, Sony, Tokyo, Japan) mounted on a microscope
(Olympus BX50F, Olympus Optical Co., Tokyo) was con-
nected to an IBM personal computer (PC). The image sig-
nals acquired by the PC were then evaluated using Image
Pro Plus, Version 3.0 (Media Cybernetics Co., Silver Spring,
MD, U.S.A.). Image analyses were conducted on four repre-
sentative areas of the slides, under constant magnification
(×200), after which the percentage of apoptotic cells was
determined.
Western blot analysis
Cells were grown for 24 hr in 100 mm culture dishes, sub-
jected to serum starvation for 48 hr, and treated with S1P or
vehicle for the indicated times. They were then harvested
and lysed in radioimmunoprecipitation (RIPA) buffer (150
mM NaCl, 1% NP-40, 0.5% deoxycholate, 0.1% SDS, and
50 nM Tris [pH 8.0]) containing the phosphatase inhibitor
Na3VO4 (10 mM), and the protease inhibitors phenylmethyl-
sulfonyl fluoride (200 mM) and aprotinin (10  g/mL). Ten
to 20 micrograms of protein per lane was separated via SDS-
polyacrylamide gel electrophoresis, and blotted onto nitro-
cellulose membranes, which were then saturated with 2%
bovine serum albumin in Tris-buffered saline containing
0.05% Tween 20. The blots were then incubated with the
designated primary antibodies at a 1:1,000 dilution, and then
incubated further with horseradish peroxidase-conjugated
secondary antibody. The bound antibodies were detected
using a Renaissance chemiluminescence kit (Dupont NEN,
Boston, MA, U.S.A.).
Statistical analysis
All experiments were independently repeated at least twice.
Statistics were determined via Student’s t-test (SPSS 12.0
for Windows); p values <0.05 as compared with control cells
were considered to be statistically significant.
RESULTS
Sphingosine 1-phosphate shows proliferation inhibitory
effects in B16 melanoma cells
S1P was found to inhibit the proliferation of B16 melanoma
cells (Fig. 1). After 24 hr, S1P significantly inhibited cell
growth at concentrations in excess of 5  M (p<0.05). Indeed,
after 24 hr, S1P induced the shrinkage, rounding and detach-
ment of cells, whereas serum deprivation alone had no detec-
table effects on cell morphology (data not shown). To assess
the effect of S1P on melanogenesis in B16 melanoma cells,
melanin content was measured as described in method. The
melanin synthesis of B16 melanoma cells was not signifi-
cantly affected by S1P (p>0.05, Fig. 2).
Sphingosine 1-phosphate induces apoptosis of B16
melanoma cells via caspase-3 activation
In order to identify more precisely the inhibitory effects of
S1P on the growth of B16 melanoma cells, we attempted to
determine whether S1P induced apoptosis in B16 melanoma
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Fig. 1. Treatment with more than 5  M inhibited the growth of B16
melanoma cells (*: p<0.05). The control was treated with vehicle
instead of S1P for 24 hr. Optical density was determined at a wave-
length of 540 nm. The experiment was repeated five times.
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Fig. 2. Melanin content was not significantly affected by S1P (p>
0.05).
Fig. 3. The number of apoptotic B16 melanoma cells increased
in the S1P treatment group (10  M for 24 hr) (B) as compared to
the vehicle-treated control group (A). (TUNEL, ×200), (Inset: apop-
totic cells, ×400).
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cells. Using TUNEL assays, the numbers of positively stained
cells were found to have increased after 72 hr of treatment
with 10  M of S1P, whereas the majority of serum-deprived
control cells evidenced negative findings (Fig. 3). This was
quantitatively analyzed as described in the methods, and the
percentage of apoptotic cells after 24 hr of treatment with 10
M of S1P was found to have been increased significantly as
compared with the control group (p<0.001) (Table 1). 
In order to further characterize the apoptotic effects of S1P
on B16 melanoma cells, we conducted Western blot analy-
sis for caspase-3 activation. As shown in Fig. 4, 10  M of
S1P induced time-dependent caspase-3 activation. 
Receptors of sphingosine 1-phosphate (Edg1/S1P1, Edg5/
S1P2, Edg3/S1P3) are expressed in B16 melanoma cells
To identify the receptors of sphingosine 1-phosphate on
the surfaces of B16 melanoma cells, we conducted immuno-
cytochemical staining with anti Edg-1, -3, and -5, as des-
cribed in the methods. The plasma membrane of B16 mela-
noma cells stained positively for Edg-1, Edg-3, and Edg-5
(Fig. 5A). These expressions were verified via Western blot
analysis (Fig. 5B).
The apoptotic effect of sphinosine 1-phosphate is Edg-
independent
In order to determine whether S1P triggers apoptosis via
Edg receptors, we employed dihydro-S1P (Di-S1P) as the
method of Van Brocklyn et al. (15), a structural analogue of
*, p<0.001; control group, vehicle treated; S1P group, 10  M of S1P
treatment for 24 hr.
TUNEL positive cells (%)
(mean±SD)
Groups
Control group 8.80±1.96
S1P group 80.92±11.19 *
Table 1. The comparison of the TUNEL positive cells 
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Fig. 6. MTT dye reduction assays were conducted as described
in the methods section (Optical density at 540 nm). 24 hr of treat-
ment with dihydro-S1P (10  M), a structural analogue of S1P that
binds and activates only Edg receptors, dose not induce cell death
in contrast to the effect of S1P (*, p<0.05). This result suggested
that the apoptotic effects of S1P were Edg-independent. This ex-
periment was repeated three times.
Fig. 4. Western blot analysis of the cell extracts from B16 cells treat-
ed with 10  M S1P using caspase-3 antibody showed decreased
inactive casapse-3 (35 kDa) and increased active cleaved caspase-
3 (17, 19 kDa). 
Fig. 5. (A) Cell surface receptors of S1P are expressed abundantly
in B16 melanoma cells (Immunocytochemistry, ×400). (B) West-
ern blot analysis of cell extracts from B16 melanoma cells using
specific anti-Edg antibodies shows 45 kDa proteins.
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Fig. 7. Serum-deprived cells were preincubated for 24 hr with 10
ng/mL of pertussis toxin (PTX) or vehicle, and incubated further in
the presence of PTX or vehicle, together with S1P (10  M). The
MTT dye reduction assays were conducted as was described in
the methods section. After time, cell viability was found to have
been significantly decreased after treatment with S1P, with or with-
out PTX (*: p<0.05). PTX failed to reverse the apoptotic effects of
S1P. This experiment was repeated three times.
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S1P that binds and activates Edg receptors, and exerts only
receptor-associated signals. 10  M of Di-S1P induced a slight
increase in B16 melanoma cell viability, but exhibited no
significant effects in the MTT dye reduction assay (p>0.05)
(Fig. 6). This result was contrasted with the apoptotic effects
evidenced by S1P. Furthermore, pertussis toxin (PTX), which
inhibits cAMP pathway, did not block the apoptotic effects
of S1P on B16 melanoma cells (p>0.05) (Fig. 7). These results
indicated that the apoptotic effects of S1P occurred via a PTX-
insensitive, Edg-independent pathway. 
Sphingosine 1-phosphate induces the ERK activation and
its inhibition reverses cell death 
The antiapoptotic functions of ERK, which are known to
be activated via Edg receptors, have been well established,
and S1P was reported to exert protective effects against apop-
tosis via ERK and Akt activation in the melanocytes (25).
In order to characterize the survival mechanisms by which
S1P counteracts its own apoptotic effects, we investigated
the activation of ERK by S1P and its responsive role, using
UO126, the MEK inhibitor that is a kinase upstream of ERK.
According to our results, S1P induced more intense ERK
activation than control or Di-S1P until 12 hr, and UO126
blocked this effect (Fig. 8). Interestingly, UO126 pretreat-
ment reversed S1P-induced cell death (Fig. 9, p<0.05). How-
ever, UO126 did not work at 24 hr. These results suggested
that S1P induced cell death via ERK activation, at least dur-
ing the early stages.
DISCUSSION
We determined that sphingosine 1-phosphate induced
apoptosis in B16 melanoma cells. The evidence for S1P-in-
duced apoptosis are as follows; first, 24 hr of treatment with
more than 5  M of S1P resulted in a significant inhibition of
B16 melanoma cell growth, second, S1P-treated B16 mela-
noma cells exhibited round, fragmented and condensed nuclei
when stained with TUNEL method, and finally, S1P treat-
ment resulted in a stimulation of caspase-3 cleavage, followed
by a loss of cell viability. We observed that B16 melanoma
cells expressed the Edg receptors of S1P, but the apoptotic
effects of S1P were found not to be dependent on the activa-
tion of the receptors, and were not blocked by treatment with
pertussis toxin. S1P was shown to induce activation of the
ERK, and UO126, the MEK inhibitor that is a kinase ups-
tream of the ERK, reversed B16 melanoma cell death induced
by S1P. Collectively, our results suggest that S1P induces
apoptosis involving the activation of the ERK and caspase,
via an Edg receptor-independent and pertussis toxin-insensi-
tive pathway.
This is, to our knowledge, the first study to report that S1P
induces apoptosis in B16 melanoma cells. The exact mecha-
nism underlying the apoptotic effects of S1P remains to be
elucidated. According to our results, the pathway is Edg-
independent, and this is consistent with other reports that
reveal the proapoptotic effects of S1P. Recent research into
the apoptotic effects of S1P in mesangial cells showed that
they were Edg-independent, and the results of this research
essentially suggested that the conversion of S1P into sphin-
gosine constituted the relevant mechanism (24). However,
the conversion of S1P into sphingosine was not relevant in
our study, because S1P-induced apoptosis was caspase-depen-
dent, whereas the cytotoxic effects of sphingosine occurred
in a caspase-independent manner (26). In addition, both sph-
ingolipids required similarly high concentrations for the in-
duction of cell death, which militates against the possibility
that micromolar concentrations of S1P are being converted
completely to micromolar concentrations of sphingosine (27).
Fig. 8. Serum-deprived cells were preincubated for 1 hr with 10
M of UO126 or vehicle, and incubated further in the presence
of UO126 (the MAP kinase inhibitor) or vehicle, together with 10
M of S1P or dihydro-S1P, for the indicated time periods. Western
blot analysis was conducted as described in the methods sec-
tion. This figure indicates that S1P activates ERK, and UO126 in-
hibits the activation of ERK.
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Fig. 9. Serum-deprived cells were preincubated for 1 hr with 10
M of UO126 or vehicle, and incubated further in the presence
of UO126 or vehicle, together with 10  M of S1P, for the indicat-
ed time periods. MTT dye reduction assays were conducted as
described in the methods section. After 12 hr, S1P significantly
induced cell death, and UO126 reversed S1P-induced cell death
(*, p< 0.05). This result indicated that S1P induced cell death via
ERK activation in early stages. This experiment was repeated
three times.
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Davaille et al. (27) suggested that the effects of S1P were con-
centration-dependent. Whereas micromolar concentrations
of S1P exerted proapoptotic effects, which were attributed
to an Edg-independent mechanism, submicromolar S1P con-
centrations evidenced antiapoptotic, proliferative effects via
Edg-receptors, and ERK and PI3K/Akt stimulation in hep-
atic myofibroblasts. Liu et al. (28) showed that sphingosine
kinase type 2 was a putative BH3-only protein that induced
apoptosis, whereas sphingosine kinase type 1 stimulated both
growth and survival. Sphingosine kinase type 2-induced apop-
tosis was found to be preceded by caspase-3 activation, and
occurred independently of Edg receptor activation. This en-
zyme was also over-expressed under serum starvation condi-
tions. Down regulation of gene of S1P phosphates 1, which
dephosphorylates S1P selectively, was detected in stress con-
ditions in NIH3T3 cells (29). Indeed, S1P itself is known
to stimulate sphingosine kinase (9). In hippocampal neurons
or ovarian cancer cells, S1P-triggered apoptosis relies on a
calcium-dependent pathway (20, 21). S1P is capable of mobi-
lizing calcium in the ER, in the absence of plasma membrane
S1P receptors (30). Collecting the above findings, S1P is shown
to exert proapoptotic signal via Edg-independent intracellu-
lar pathway, which may activate calcium or sphingosin kinase
type 2 and caspase cascade. It is possible that sphingosin kinase
type 2 was over expressed in our study, because we deprived
serum from culture media to devoid the effect of S1P exist-
ing serum. 
By the way, it is interesting the role of the ERK in apop-
tosis in our study, since the ERK is well known to mediate
mitogenic and cell survival effects. However, there are reports
that ERK can be associated with apoptosis in certain condi-
tions. In neuronal cells, stimuli that induce prolonged ERK
activation, most notably oxidative stress or ischemia, also
trigger cell death (31, 32). Transient ERK activation stimu-
lates cell proliferation, but prolonged ERK pathway activa-
tion results in cell cycle arrest. However, the mediators of cell
death remain enigmatic. Recently, Cagnol et al. (33) showed
that caspase-8 was the substrate of prolonged activated ERK
in HEK293 cells. In our study, S1P was shown to induce the
ERK activation proceeding to the activation of caspase-3 in
B16 melanoma cells. This suggested that S1P activates the
ERK and then caspases, leading cell death. We are current-
ly undertaking a series of S1P-induced caspases cascade and
Bcl-2/Bax protein changes. In melanoma cell lines, Bcl-2
protein is highly expressed to resist apoptosis. Recent study
showed Bcl-2 over expression stimulated sphingosine kinase
type 1 in human melanoma cell line (34).
In conclusion, sphingosine 1-phosphate exerts apoptotic
effects on B16 melanoma cells, an effect which is mediated
by ERK and caspase-3 activation. It is a PTX-insensitive and
Edg receptor-independent pathway. The downstream path-
ways associated with the apoptotic effects of S1P should be
further investigated. Furthermore, the finding that high dose
of S1P can be proapoptotic should be proven also in a couple
of other (human) melanoma cell lines. Then it would become
clear, whether S1P-induced apoptosis is general for melanoma
cells or it is a special feature of B16 melanoma cells. 
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